Other examples including higher prevalence of TP53 mutations, EGFR mutations, and TERT amplifications in lung adenocarcinoma with BMs [68], and higher frequency of MYC, YAP1, and MMP13 amplification in BMs of NSCLC [70]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.